T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
GE HealthCare
GEHC
$33.2B
| $906M | 0.11% |
9,961,518
-2,132,389
| -18% | -$177M |
|
177
Dynatrace
DT
$14B
| $904M | 0.11% |
19,471,967
-2,449,634
| -11% | -$128M |
|
178
Amgen
AMGN
$226B
| $892M | 0.11% |
3,137,491
-3,427,219
| -52% | -$1B |
|
179
Tractor Supply
TSCO
$19.1B
| $872M | 0.11% |
16,653,105
+1,844,295
| +12% | +$88.1M |
|
180
Regeneron Pharmaceuticals
REGN
$82.8B
| $869M | 0.11% |
902,613
+184,561
| +26% | +$175M |
|
181
Broadridge
BR
$19.3B
| $854M | 0.1% |
4,168,197
+28,180
| +0.7% | +$5.68M |
|
182
CVS Health
CVS
$123B
| $853M | 0.1% |
10,699,034
+13,268
| +0.1% | +$1.01M |
|
183
Wingstop
WING
$3.1B
| $833M | 0.1% |
2,273,542
+101,917
| +5% | +$31.7M |
|
184
Tenet Healthcare
THC
$21.5B
| $832M | 0.1% |
7,915,000
+790,684
| +11% | +$71M |
|
185
Humana
HUM
$46.3B
| $832M | 0.1% |
2,399,204
-1,498,902
| -38% | -$568M |
|
186
Southern Copper
SCCO
$161B
| $828M | 0.1% |
8,483,629
+1,301,376
| +18% | +$103M |
|
187
International Paper
IP
$21.8B
| $825M | 0.1% |
21,135,702
+5,492,035
| +35% | +$199M |
|
188
Hubbell
HUBB
$26.9B
| $822M | 0.1% |
1,980,456
+286,134
| +17% | +$104M |
|
189
Floor & Decor
FND
$6.42B
| $815M | 0.1% |
6,291,056
-2,275
| -0% | -$258K |
|
|
EXE
190
Expand Energy Corp
EXE
$21.9B
| $805M | 0.1% |
9,059,644
+6,338,963
| +233% | +$509M |
|
191
Tyson Foods
TSN
$20B
| $804M | 0.1% |
13,697,401
+128,274
| +0.9% | +$7.03M |
|
192
West Pharmaceutical
WST
$24.5B
| $804M | 0.1% |
2,032,890
-294,504
| -13% | -$109M |
|
193
Target
TGT
$70.7B
| $795M | 0.1% |
4,488,452
-137,423
| -3% | -$20.9M |
|
194
AvalonBay Communities
AVB
$26.5B
| $791M | 0.1% |
4,264,288
-1,280,508
| -23% | -$230M |
|
195
Kimberly-Clark
KMB
$36.8B
| $762M | 0.09% |
5,893,146
+944,920
| +19% | +$116M |
|
196
BILL Holdings
BILL
$4.86B
| $759M | 0.09% |
11,046,372
-11,439
| -0.1% | -$800K |
|
197
Cintas
CTAS
$81.4B
| $758M | 0.09% |
4,410,992
-355,244
| -7% | -$54.7M |
|
198
DoorDash
DASH
$93B
| $753M | 0.09% |
5,469,647
+242,956
| +5% | +$28.6M |
|
199
Globant
GLOB
$1.68B
| $752M | 0.09% |
3,726,183
-225,558
| -6% | -$50.7M |
|
200
SiteOne Landscape Supply
SITE
$4.22B
| $743M | 0.09% |
4,254,443
-949,570
| -18% | -$157M |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.